AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. META
  4. [Form 4] Meta Platforms, Inc. Insider Trading Activity

[Form 4] Meta Platforms, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

Christopher K. Cox, Chief Product Officer at Meta Platforms (META), reported multiple sales of Class A common stock executed on 08/06/2025 under a Rule 10b5-1 trading plan adopted May 5, 2025. The filing lists seven sale tranches of 2,266, 983, 2,451, 1,421, 5,921, 1,560 and 398 shares, which together total 15,000 shares, sold at weighted-average prices with ranges approximately from $764.235 to $770.88 per share. After these transactions the Form 4 shows 222,205 Class A shares held of record by the Christopher K. Cox Revocable Trust and 55,046 shares held by the Cox-Vadakan Irrevocable Remainder Trust. The sales were disclosed on Form 4 and signed by an attorney-in-fact.

Christopher K. Cox, Chief Product Officer di Meta Platforms (META), ha comunicato diverse vendite di azioni ordinarie di Classe A eseguite il 6 agosto 2025 nell'ambito di un piano di negoziazione ai sensi della Regola 10b5-1 adottato il 5 maggio 2025. Il documento indica sette tranche di vendita di 2,266, 983, 2,451, 1,421, 5,921, 1,560 e 398 azioni, per un totale di 15,000 azioni, vendute a prezzi medi ponderati compresi approssimativamente tra $764.235 e $770.88 per azione. Dopo queste transazioni il Modulo 4 riporta 222,205 azioni di Classe A intestate al Christopher K. Cox Revocable Trust e 55,046 azioni detenute dal Cox-Vadakan Irrevocable Remainder Trust. Le vendite sono state divulgate nel Modulo 4 e firmate da un mandatario munito di procura.

Christopher K. Cox, Chief Product Officer de Meta Platforms (META), inform贸 varias ventas de acciones ordinarias Clase A ejecutadas el 6 de agosto de 2025 bajo un plan de negociaci贸n conforme a la Regla 10b5-1 adoptado el 5 de mayo de 2025. La presentaci贸n enumera siete tramos de venta de 2,266, 983, 2,451, 1,421, 5,921, 1,560 y 398 acciones, que suman un total de 15,000 acciones, vendidas a precios medios ponderados que oscilaron aproximadamente entre $764.235 y $770.88 por acci贸n. Tras estas transacciones, el Formulario 4 muestra 222,205 acciones de Clase A registradas a nombre del Christopher K. Cox Revocable Trust y 55,046 acciones en poder del Cox-Vadakan Irrevocable Remainder Trust. Las ventas se divulgaron en el Formulario 4 y el documento fue firmado por un apoderado.

Meta Platforms(META)鞚� 斓滉碃鞝滍拡毂呾瀯鞛�(Chief Product Officer) Christopher K. Cox電� 2025雲� 8鞗� 6鞚�鞐� Rule 10b5-1 瓯半灅 瓿勴殟鞐� 霐半澕 鞐煬 彀 Class A 氤错喌欤茧ゼ 毵り皝頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟(頃措嫻 瓿勴殟鞚� 2025雲� 5鞗� 5鞚� 毂勴儩). 鞝滌稖 靹滊鞐愲姅 2,266, 983, 2,451, 1,421, 5,921, 1,560, 398欤� 霌� 7臧� 韸鸽灉旃橁皜 旮办灛霅橃柎 鞛堨溂氅� 頃╆硠電� 15,000欤�搿�, 欤茧嫻 臧�欷戫弶攴� 臧�瓴╈潃 雽�霝� $764.235鞐愳劀 $770.88 靷澊鞓�鞀惦媹雼�. 鞚� 瓯半灅 頉� Form 4鞐愲姅 Christopher K. Cox Revocable Trust 氇呾潣搿� 222,205欤�, Cox-Vadakan Irrevocable Remainder Trust 氇呾潣搿� 55,046欤缄皜 霌膘灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 毵り皝鞚� Form 4鞐� 瓿奠嫓霅橃棃瓿� 鞙勳瀯氚涭潃 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.

Christopher K. Cox, Chief Product Officer de Meta Platforms (META), a d茅clar茅 plusieurs cessions d'actions ordinaires de classe A ex茅cut茅es le 6 ao没t 2025 dans le cadre d'un plan de n茅gociation conforme 脿 la r猫gle 10b5-1 adopt茅 le 5 mai 2025. Le d茅p么t mentionne sept tranches de vente de 2,266, 983, 2,451, 1,421, 5,921, 1,560 et 398 actions, soit un total de 15,000 actions, vendues 脿 des prix moyens pond茅r茅s allant approximativement de $764.235 脿 $770.88 par action. Apr猫s ces op茅rations, le Formulaire 4 indique que 222,205 actions de classe A sont enregistr茅es au nom du Christopher K. Cox Revocable Trust et que 55,046 actions sont d茅tenues par le Cox-Vadakan Irrevocable Remainder Trust. Les ventes ont 茅t茅 divulgu茅es dans le Formulaire 4 et sign茅es par un mandataire.

Christopher K. Cox, Chief Product Officer von Meta Platforms (META), meldete mehrere Verk盲ufe von Class-A-Stammaktien, die am 6. August 2025 im Rahmen eines nach Rule 10b5-1 eingerichteten Handelsplans ausgef眉hrt wurden (Plan angenommen am 5. Mai 2025). Die Einreichung listet sieben Verkaufslose 眉ber 2,266, 983, 2,451, 1,421, 5,921, 1,560 und 398 Aktien, insgesamt 15,000 Aktien, zu gewichtet durchschnittlichen Preisen von etwa $764.235 bis $770.88 pro Aktie. Nach diesen Transaktionen weist das Formular 4 222,205 Class-A-Aktien aus, die im Register des Christopher K. Cox Revocable Trust stehen, und 55,046 Aktien, die vom Cox-Vadakan Irrevocable Remainder Trust gehalten werden. Die Verk盲ufe wurden im Formular 4 offengelegt und von einem Bevollm盲chtigten unterschrieben.

Positive
  • Sales executed under a Rule 10b5-1 trading plan adopted May 5, 2025, indicating prearranged dispositions.
  • Detailed price disclosure: filing includes weighted-average prices and explicit price ranges for each tranche, improving transparency.
  • Substantial post-sale holdings disclosed: 222,205 shares in the Christopher K. Cox Revocable Trust and 55,046 shares in the Cox-Vadakan Irrevocable Remainder Trust.
Negative
  • None.

Insights

TL;DR: Insider sales of 15,000 META shares executed under a documented 10b5-1 plan; disclosure is granular and appears routine.

The filing reports seven tranches sold on 08/06/2025 under a Rule 10b5-1 plan adopted May 5, 2025, with weighted-average prices and explicit price ranges provided in footnotes. The detailed tranche sizes and price bands reduce ambiguity about execution pricing. The reporting person retains material indirect holdings in two trusts as disclosed, which limits interpretation that the sales exhausted insider ownership. Overall this reads as prearranged, routine disposition rather than a surprise market event.

TL;DR: Use of a 10b5-1 plan and explicit price-range footnotes improves governance transparency; disclosure follows Form 4 standards.

The report specifies that the sales were effected pursuant to a 10b5-1 trading plan adopted May 5, 2025, and provides weighted-average prices plus price ranges for each tranche. The filing also lists indirect beneficial ownership via the Christopher K. Cox Revocable Trust and the Cox-Vadakan Irrevocable Remainder Trust. From a governance perspective, prearranged plan execution and granular price disclosure reduce potential signaling risk and increase transparency for shareholders and regulators.

Christopher K. Cox, Chief Product Officer di Meta Platforms (META), ha comunicato diverse vendite di azioni ordinarie di Classe A eseguite il 6 agosto 2025 nell'ambito di un piano di negoziazione ai sensi della Regola 10b5-1 adottato il 5 maggio 2025. Il documento indica sette tranche di vendita di 2,266, 983, 2,451, 1,421, 5,921, 1,560 e 398 azioni, per un totale di 15,000 azioni, vendute a prezzi medi ponderati compresi approssimativamente tra $764.235 e $770.88 per azione. Dopo queste transazioni il Modulo 4 riporta 222,205 azioni di Classe A intestate al Christopher K. Cox Revocable Trust e 55,046 azioni detenute dal Cox-Vadakan Irrevocable Remainder Trust. Le vendite sono state divulgate nel Modulo 4 e firmate da un mandatario munito di procura.

Christopher K. Cox, Chief Product Officer de Meta Platforms (META), inform贸 varias ventas de acciones ordinarias Clase A ejecutadas el 6 de agosto de 2025 bajo un plan de negociaci贸n conforme a la Regla 10b5-1 adoptado el 5 de mayo de 2025. La presentaci贸n enumera siete tramos de venta de 2,266, 983, 2,451, 1,421, 5,921, 1,560 y 398 acciones, que suman un total de 15,000 acciones, vendidas a precios medios ponderados que oscilaron aproximadamente entre $764.235 y $770.88 por acci贸n. Tras estas transacciones, el Formulario 4 muestra 222,205 acciones de Clase A registradas a nombre del Christopher K. Cox Revocable Trust y 55,046 acciones en poder del Cox-Vadakan Irrevocable Remainder Trust. Las ventas se divulgaron en el Formulario 4 y el documento fue firmado por un apoderado.

Meta Platforms(META)鞚� 斓滉碃鞝滍拡毂呾瀯鞛�(Chief Product Officer) Christopher K. Cox電� 2025雲� 8鞗� 6鞚�鞐� Rule 10b5-1 瓯半灅 瓿勴殟鞐� 霐半澕 鞐煬 彀 Class A 氤错喌欤茧ゼ 毵り皝頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟(頃措嫻 瓿勴殟鞚� 2025雲� 5鞗� 5鞚� 毂勴儩). 鞝滌稖 靹滊鞐愲姅 2,266, 983, 2,451, 1,421, 5,921, 1,560, 398欤� 霌� 7臧� 韸鸽灉旃橁皜 旮办灛霅橃柎 鞛堨溂氅� 頃╆硠電� 15,000欤�搿�, 欤茧嫻 臧�欷戫弶攴� 臧�瓴╈潃 雽�霝� $764.235鞐愳劀 $770.88 靷澊鞓�鞀惦媹雼�. 鞚� 瓯半灅 頉� Form 4鞐愲姅 Christopher K. Cox Revocable Trust 氇呾潣搿� 222,205欤�, Cox-Vadakan Irrevocable Remainder Trust 氇呾潣搿� 55,046欤缄皜 霌膘灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 毵り皝鞚� Form 4鞐� 瓿奠嫓霅橃棃瓿� 鞙勳瀯氚涭潃 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.

Christopher K. Cox, Chief Product Officer de Meta Platforms (META), a d茅clar茅 plusieurs cessions d'actions ordinaires de classe A ex茅cut茅es le 6 ao没t 2025 dans le cadre d'un plan de n茅gociation conforme 脿 la r猫gle 10b5-1 adopt茅 le 5 mai 2025. Le d茅p么t mentionne sept tranches de vente de 2,266, 983, 2,451, 1,421, 5,921, 1,560 et 398 actions, soit un total de 15,000 actions, vendues 脿 des prix moyens pond茅r茅s allant approximativement de $764.235 脿 $770.88 par action. Apr猫s ces op茅rations, le Formulaire 4 indique que 222,205 actions de classe A sont enregistr茅es au nom du Christopher K. Cox Revocable Trust et que 55,046 actions sont d茅tenues par le Cox-Vadakan Irrevocable Remainder Trust. Les ventes ont 茅t茅 divulgu茅es dans le Formulaire 4 et sign茅es par un mandataire.

Christopher K. Cox, Chief Product Officer von Meta Platforms (META), meldete mehrere Verk盲ufe von Class-A-Stammaktien, die am 6. August 2025 im Rahmen eines nach Rule 10b5-1 eingerichteten Handelsplans ausgef眉hrt wurden (Plan angenommen am 5. Mai 2025). Die Einreichung listet sieben Verkaufslose 眉ber 2,266, 983, 2,451, 1,421, 5,921, 1,560 und 398 Aktien, insgesamt 15,000 Aktien, zu gewichtet durchschnittlichen Preisen von etwa $764.235 bis $770.88 pro Aktie. Nach diesen Transaktionen weist das Formular 4 222,205 Class-A-Aktien aus, die im Register des Christopher K. Cox Revocable Trust stehen, und 55,046 Aktien, die vom Cox-Vadakan Irrevocable Remainder Trust gehalten werden. Die Verk盲ufe wurden im Formular 4 offengelegt und von einem Bevollm盲chtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cox Christopher K
(Last) (First) (Middle)
C/O META PLATFORMS, INC.
1 META WAY
(Street)
MENLO PARK CA 94025
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Meta Platforms, Inc. [ META ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Product Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/06/2025 S(1) 2,266 D $764.739(2) 234,939 I Christopher K. Cox Revocable Trust(3)
Class A Common Stock 08/06/2025 S(1) 983 D $765.4284(4) 233,956 I Christopher K. Cox Revocable Trust(3)
Class A Common Stock 08/06/2025 S(1) 2,451 D $766.7718(5) 231,505 I Christopher K. Cox Revocable Trust(3)
Class A Common Stock 08/06/2025 S(1) 1,421 D $768.0725(6) 230,084 I Christopher K. Cox Revocable Trust(3)
Class A Common Stock 08/06/2025 S(1) 5,921 D $768.9923(7) 224,163 I Christopher K. Cox Revocable Trust(3)
Class A Common Stock 08/06/2025 S(1) 1,560 D $769.8574(8) 222,603 I Christopher K. Cox Revocable Trust(3)
Class A Common Stock 08/06/2025 S(1) 398 D $770.7644(9) 222,205 I Christopher K. Cox Revocable Trust(3)
Class A Common Stock 55,046 I Cox-Vadakan Irrevocable Remainder Trust(10)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2025.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $764.235 to $765.195 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $765.25 to $766.055 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $766.31 to $767.13 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $767.50 to $768.49 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $768.50 to $769.44 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $769.505 to $770.14 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $770.58 to $770.88 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
10. Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust.
/s/ Erin Guldiken, attorney-in-fact for Christopher K. Cox 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

Who filed the Form 4 for META?

The Form 4 was filed on behalf of Christopher K. Cox, Chief Product Officer of Meta Platforms (META); the signature on the filing was provided by an attorney-in-fact.

What transactions are reported in the META Form 4?

The filing reports multiple sales of Class A common stock executed on 08/06/2025 under a Rule 10b5-1 trading plan.

How many shares did Christopher K. Cox sell and what were the prices?

Seven tranches of 2,266; 983; 2,451; 1,421; 5,921; 1,560; and 398 shares were sold (totaling 15,000 shares) at weighted-average prices with ranges approximately $764.235 to $770.88 per share.

When was the 10b5-1 trading plan adopted for these META sales?

The Form 4 states the Rule 10b5-1 trading plan was adopted on May 5, 2025.

How many META shares does Cox beneficially hold after the transactions?

The filing shows 222,205 Class A shares held of record by the Christopher K. Cox Revocable Trust and 55,046 shares held by the Cox-Vadakan Irrevocable Remainder Trust.
Stock META logo
Meta Platforms Inc

NASDAQ:META

META Rankings

#7 Ranked by Market Cap
#2067 Ranked by Dividends

META Latest News

Jul 30, 2025
Meta Reports Second Quarter 2025 Results
Jul 1, 2025
Meta to Announce Second Quarter 2025 Results
Jun 26, 2025
Invenergy to Provide Meta with Nearly 800 MW, Supporting Data Center Operations
Jun 18, 2025
IAS Launches New AI-Driven Contextual Category Reporting for Meta Platforms, Maximizing Optimization and Precision for Advertisers
Jun 12, 2025
Scale AI Announces Next Phase of Company鈥檚 Evolution

META Latest SEC Filings

Aug 8, 2025
[144] Meta Platforms, Inc. SEC Filing
Aug 7, 2025
[Form 4] Meta Platforms, Inc. Insider Trading Activity
Aug 7, 2025
[Form 4] Meta Platforms, Inc. Insider Trading Activity
Aug 7, 2025
[144] Meta Platforms, Inc. SEC Filing
Aug 6, 2025
[Form 4] Meta Platforms, Inc. Insider Trading Activity

META Stock Data

1.94T
2.17B
0.07%
80.04%
1.02%
Internet Content & Information
Services-computer Programming, Data Processing, Etc.
United States
MENLO PARK